The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The PCR And Realtime PCR Testing Market During The Forecast Period 2026–2030?
The pcr and realtime pcr testing market has experienced robust growth in recent years. It is projected to expand from $11.12 billion in 2025 to $12.02 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.1%. The market’s historical growth can be attributed to the broader adoption of molecular diagnostics, the increasing prevalence of infectious diseases, the expansion of genomics research activities, the rising application of pcr in clinical diagnostics, and the development of academic research infrastructure.
The pcr and realtime pcr testing market size is projected for substantial expansion in the coming years. This market is set to reach $16.38 billion by 2030, showing a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is driven by factors such as the increasing need for personalized medicine, greater acceptance of digital pcr technologies, the spread of decentralized diagnostic testing, increased funding in life science research, and the expanding application of pcr in oncology and genetic testing. Key developments expected during this period include the wider embrace of high-throughput pcr platforms, a rise in demand for multiplex real-time pcr assays, further integration of automated sample preparation systems, broader applications of digital pcr, and a heightened emphasis on contamination-free testing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2841&type=smp
What Underlying Factors Are Accelerating The Growth Of The PCR And Realtime PCR Testing Market?
The increased endorsements of personalized medicines are anticipated to boost the PCR And real-time PCR testing market in the coming years. Personalized medicines are defined as therapeutic solutions or treatments uniquely adapted for each patient. Their development relies on a patient’s genetic, biomarker, phenotypic, or psychosocial profiles, which allow for predicting an individual’s reaction to a specific treatment. Within personalized medicine, PCR and Real-Time PCR facilitate the accurate detection of genetic alterations, enabling the customization of treatments to meet individual patient requirements and enhance therapeutic results. As an illustration, in February 2024, data from the Personalised Medicine Coalition, a US-based hospital and health care organization, indicated that in 2023, the FDA sanctioned 16 novel personalized treatments for patients with rare diseases, a significant rise from six in 2022. Consequently, the growing number of approvals for personalized medicines is a key factor propelling the PCR And real-time PCR testing market.
What Market Segments Are Evaluated Within The PCR And Realtime PCR Testing Market?
The pcr and realtime pcr testing market covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Quantitative PCR, Digital PCR
3) By Application: Clinical Diagnostics, Life Science Research, Industrial Applications, Other Applications
4) By End-Use: Academic And Research Institutes, Pharmaceutical And Biotechnology, Clinical Diagnostics Labs And Hospitals, Other End Users
Subsegments:
1) By Consumables And Reagents: PCR Reagents, PCR Kits, PCR Primers And Probes, DNA And RNA Extraction Kits
2) By Instruments: PCR Machines/Amplifiers, Real-Time PCR Systems, Thermal Cyclers, Automated PCR Systems
3) By Software And Services: Data Analysis Software, PCR Software, Maintenance And Support Services, Training Services
What Industry Trends Are Redefining The PCR And Realtime PCR Testing Market?
Leading companies in the PCR and real time PCR testing market are developing highly specific detection kits, such as variant targeted RT PCR assays, to better monitor viral evolution and support epidemiological surveillance efforts. These variant-targeted RT PCR assays are molecular diagnostic tools crafted to identify specific genetic mutations or variations within a virus, enabling the precise identification of particular viral strains or sub-variants. For instance, in January 2023, Roche, a Switzerland based diagnostics company, introduced the VirSNiP SARS CoV 2 Spike F486P assay, a real time PCR test specifically designed to detect the F486P mutation found in the XBB.1.5 Omicron sub-variant. This kit is compatible with standard real-time PCR platforms including LightCycler 480 II and cobas z 480, providing researchers with accurate lineage differentiation to assist in variant monitoring.
Who Are The Top Market Participants Influencing The PCR And Realtime PCR Testing Market?
Major companies operating in the pcr and realtime pcr testing market are Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc.
Read the full pcr and realtime pcr testing market report here:
https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report
Which Region Is Projected To Dominate The PCR And Realtime PCR Testing Market During The Forecast Period?
Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2025. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored PCR And Realtime PCR Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2841&type=smp
Browse Through More Reports Similar to the Global PCR And Realtime PCR Testing Market 2026, By The Business Research Company
Real Time Pcr Digital Pcr And End Point Pcr Market Report 2026
Multiplex Pcr Assays Market Report 2026
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report
Polymerase Chain Reaction Pcr Technologies Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model